Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Alzheimer Disease: HELP
Kristin Kahle-Wrobleski
Based on 26 articles published since 2010
(Why 26 articles?)
||||
Expertise Level
The expertise of Kristin Kahle-Wrobleski ranks in the
  • Top 1.5%
  • ... of 135,371 published authors worldwide on Alzheimer Disease
  • ... from 2010 through 2020
  • ... based on contributions to 26 articles on the topic.
Graphical view (beta)
Aliases Kahle-Wrobleski, Kristin   ·   Kahle-Wrobleski, K
Work Locations
Details
Most likely:    Eli Lilly Corporation      
2020
  • Mental Health and Nursing Research Team, Mental Health Promotion Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan. · Department of Health Economics and Outcomes Research, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan, and Yokohama City University, Yokohama, Japan. · Eli Lilly Japan K.K, Kobe, Japan. · Eli Lilly Australia Pty. Limited, West Ryde, Australia. · Eli Lilly and Company, Budapest, Hungary, EU. · Eli Lilly and Company, Indianapolis, IN, USA. · Geriatric Behavioral Neurology Project, New Industry Creation Hatchery Center (NICHe), Tohoku University, Sendai, Japan, Division of Nuclear Medicine, Cyclotron Radioisotope Center (CYRIC), Tohoku University, Sendai, Japan, and The Osaki-Tajiri SKIP Center, Osaki, Japan. · Department of Neurology and Neurobiology of Aging, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan. · Department of Neuropsychiatry, School of Medicine, Keio University, Tokyo, Japan. · ALZCLINIC TOKYO, Tokyo, Japan. · Pubmed 31985460
2018
  • Global Patient Outcomes & Real World Evidence, Eli Lilly Australia, NSW, Australia. · Real World Evidence, Kantar Health, New York, NY, USA. · Global Patient Outcomes and Real World Evidence, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA. · Bio-Medicines, Medical Development Unit, Eli Lilly Japan K.K., Tokyo, Japan. · Health Outcomes, Health Technology Assessment, & Real World Evidence, Medical Development Unit, Eli Lilly Japan K.K., Kobe, Japan, · Pubmed 30038495
  • Global Patient Outcomes & Real World Evidence, Eli Lilly Australia, 112 Wharf Rd, West Ryde, NSW, 2114, Australia. · Health Outcomes Practice, Kantar Health, 11 Madison Ave, Floor 12, New York, NY, 10010, USA. · Global Patient Outcomes & Real World Evidence, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA. · Medical Development Unit, Eli Lilly Japan K.K, 4-15-1, Akasaka, Minato-ku, Tokyo, 107-0052, Japan. · Health Outcomes, Health Technology Assessment, & Real World Evidence, Medical Development Unit, Eli Lilly Japan K.K, 5-1-28, Isogami-dori, chuou-ku, Kobe, 651-0086, Japan. · Pubmed 29898679
  • Eli Lilly and Company Limited, Erl Wood Manor, Sunninghill Road, Windlesham, Surrey, GU20 6PH, UK. · Eli Lilly and Company Limited, Erl Wood Manor, Sunninghill Road, Windlesham, Surrey, GU20 6PH, UK. · Eli Lilly Italia, Sesto Fiorentino, Italy. · Eli Lilly and Company, Indianapolis, IN, USA. · Indiana University School of Medicine, Indianapolis, IN, USA. · Pubmed 29615123
  • Analysis Group, Inc., Boston, MA, USA. · Eli Lilly and Company, Indianapolis, IN, USA. · Pubmed 29154268
2017
  • Kristin Kahle-Wrobleski, PhD, Global Patient Outcomes and Real World Evidence, Eli Lilly and Company, Lilly Corporate Center, Indianapolis IN 46285, USA, Phone: 317-651-9881, Fax: 317-276-5791, Email: · Pubmed 29186278
  • aRICE (The Research Institute for the Care of Older People), Royal United Hospital, Bath, UK. · bEli Lilly Deutschland GmbH, Bad Homburg, Germany. · cEli Lilly and Company, Indianapolis, Indiana, USA. · dEli Lilly Italia S.P.A., Sesto Fiorentino, Italy. · eDepartment of Neurology and Psychiatry, Clinica della Memoria, University of Rome "Sapienza", Rome, Italy. · fGerontopole, Toulouse University Hospital, INSERM 1027, Toulouse, France. · gDivisió d'Avaluació, Catalan Health Service, Barcelona, Spain. · hDepartment of Neurology, Philipps University, Marburg, Germany. · iParc Santari Saint Joan de Déu, CIBERSAM, University of Barcelona, Sant Boi de Llobregat, Barcelona, Spain. · jDivision of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institute, Stockholm, Sweden. · kEli Lilly and Company Limited, Lilly Research Centre, Windlesham, UK. · Pubmed 28611822
  • JEN Associates, Cambridge, Massachusetts. · Eli Lilly and Company, Indianapolis, Indiana. · Pubmed 28329147
  • Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA; Department of Psychiatry, Indiana University School of Medicine, Indianapolis, IN, USA. · Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA. · Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA; Department of Neurology, Indiana University School of Medicine, Indianapolis, IN, USA. · Pubmed 28229126
2016
  • Lilly Research Centre, Eli Lilly and Company Limited, Erl Wood Manor, Sunninghill Road, Windlesham Surrey, GU20 6PH, UK. · Parc Santari Sant Joan de Deu, CIBERSAM, Universitat de Barcelona, Sant Boi de Llobregat, Barcelona, Spain. · Lilly Research Centre, Eli Lilly and Company Limited, Erl Wood Manor, Sunninghill Road, Windlesham Surrey, GU20 6PH, UK. · Eli Lilly and Company, Indianapolis, IN, USA. · Agencia Qualitat I Avaluacio Sanitaries, Barcelona, Spain. · Clinica della Memoria, Department of Neurology and Psychiatry, University of Rome "Sapienza", Rome, Italy. · Department of Neurology, Philipps-University, Marburg, Germany. · RICE (The Research Institute for the Care of Older People), Royal United Hospital, Bath, UK. · Gerontopole, Toulouse University Hospital, INSERM 1027, Toulouse, France. · Division of Neurogeriatrics, Department of Neurobiology, Care Science and Society, Karolinska Institute, Stockholm, Sweden. · Pubmed 27430559
  • Analysis Group, Inc., 111 Huntington Ave, 14th floor, Boston, MA, 02199, USA. · Analysis Group, Inc., 111 Huntington Ave, 14th floor, Boston, MA, 02199, USA. · Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA. · Pubmed 27400711
  • Health Outcomes Practice, Kantar Health, 11 Madison Ave, Floor 12, New York, NY, 10010, USA. · Global Patient Outcomes & Real World Evidence, Eli Lilly Australia, 112 Wharf Rd, West, Ryde, NSW, 2114, Australia. · Global Patient Outcomes & Real World Evidence, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA. · Medical Development Unit, Eli Lilly Japan K.K, 7-1-5, Isogami-dori, chuou-ku, Kobe, 651-0086, Japan. · Health Outcomes, Health Technology Assessment, & Real World Evidence, Medical Development Unit, Eli Lilly Japan K.K, 7-1-5, Isogami-dori, chuou-ku, Kobe, 651-0086, Japan. · Pubmed 27287238
  • Lilly Deutschland GmbH, Bad Homburg, Germany. · Eli Lilly and Company, Indianapolis, IN, USA. · Eli Lilly and Company Limited, Lilly Research Centre, Windlesham, Surrey, UK. · Department of Neurology, Indiana University School of Medicine, Indianapolis, IN, USA. · Eli Lilly and Company, Toronto, Canada. · Eli Lilly and Company, Lilly House, Basingstoke, Hampshire, UK. · Faculty of Science, Liverpool Hope University, Liverpool, UK. · Pubmed 27142529
  • Institute of Psychiatry, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil. · Center for Studies and Research on Aging, Institute Vital Brazil, State University of Rio de Janeiro, Rio de Janeiro, Brazil. · Health Outcomes Practice, Kantar Health, New York, NY, USA. · Lilly Emerging Markets, Eli Lilly de México, Mexico City, Mexico. · Global Patient Outcomes and Real World Evidence, Eli Lilly and Company, Windlesham, Surrey, UK. · Global Patient Outcomes & Real World Evidence, Eli Lilly and Company, Indianapolis, IN, USA. · Pubmed 26011093
2015
  • Eli Lilly and Company, Indianapolis, IN, USA. · Lilly Research Centre, Windlesham, UK. · McGill University, Montreal, Quebec, Canada. · Columbia University, New York, NY, USA. · Harvard Medical School, Boston, MA, USA. · University of California San Diego, San Diego, CA, USA. · Pubmed 28775969
  • Eli Lilly and Company, Indianapolis, Indiana. Electronic address: · Eli Lilly and Company, Indianapolis, Indiana. · Pubmed 25676448
  • Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA. · Alzheimer's Drug Discovery Foundation and Icahn School of Medicine at Mount Sinai, New York, NY, USA. · Optum, Eden Prairie, MN, USA. · Eli Lilly and Company Limited, Windlesham, UK. · Pubmed 25410743
2014
  • Department of Neurology, Rhode Island Hospital & Alpert Medical School of Brown University, Providence, RI, USA. · Eli Lilly & Co, Inc., Indianapolis, IN, USA. · Takeda Development Center Americas, Inc., Deerfield IL, USA. · Bracket, Wayne, PA, USA. · Pfizer, Inc., New York, NY, USA. · Piramal Pharma Inc., Boston, MA, USA. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Lumos Labs, San Francisco, CA, USA. · Global R&D Partners, LLC, San Diego, CA, USA. · Merck & Co., Whitehouse Station, NJ, USA. · Department of Neurology, Mayo Clinic Arizona, Scottsdale, AZ, USA. · European Medicines Agency (EMA), London, UK. · Independent Science Writer, Elverson, PA, USA. · Alzheimer's Association, Chicago, IL, USA. Electronic address: · Pubmed 25458309
2014
  • Kristin Kahle-Wrobleski, Global Health Outcomes, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA, Tel: +1 317 709 6666 Fax: +1 317 433 6590, Email: · Pubmed 25226106
2013
Probable:    Indiana University Indianapolis   Contact    
2018
  • Eli Lilly and Company Limited, Erl Wood Manor, Sunninghill Road, Windlesham, Surrey, GU20 6PH, UK. · Eli Lilly and Company Limited, Erl Wood Manor, Sunninghill Road, Windlesham, Surrey, GU20 6PH, UK. · Eli Lilly Italia, Sesto Fiorentino, Italy. · Eli Lilly and Company, Indianapolis, IN, USA. · Indiana University School of Medicine, Indianapolis, IN, USA. · Pubmed 29615123
2017
  • Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA; Department of Psychiatry, Indiana University School of Medicine, Indianapolis, IN, USA. · Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA. · Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA; Department of Neurology, Indiana University School of Medicine, Indianapolis, IN, USA. · Pubmed 28229126
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 26 total) written by Kristin Kahle-Wrobleski about Alzheimer Disease:

  • Costs and Resource Use Associated with Community-Dwelling Patients with Alzheimer's Disease in Japan: Baseline Results from the Prospective Observational GERAS-J Study. 2020
  • Detection, diagnosis, and treatment of Alzheimer's disease dementia stratified by severity as reported by caregivers in Japan. 2018
  • Alzheimer's disease severity and its association with patient and caregiver quality of life in Japan: results of a community-based survey. 2018
  • Representativeness of European clinical trial populations in mild Alzheimer's disease dementia: a comparison of 18-month outcomes with real-world data from the GERAS observational study. 2018
  • Patient Characteristics and Outcomes Associated with Receiving an Earlier Versus Later Diagnosis of Probable Alzheimer's Disease. 2018
  • Dependence Levels as Interim Clinical Milestones Along the Continuum of Alzheimer's Disease: 18-Month Results from the GERAS Observational Study. 2017
  • Disease Progression in Mild Dementia due to Alzheimer Disease in an 18-Month Observational Study (GERAS): The Impact on Costs and Caregiver Outcomes. 2017
  • A Claims-Based Examination of Health Care Costs Among Spouses of Patients With Alzheimer's Disease. 2017
  • Assessing quality of life in Alzheimer's disease: Implications for clinical trials. 2017
  • How to deal with missing longitudinal data in cost of illness analysis in Alzheimer's disease-suggestions from the GERAS observational study. 2016
Show List of Full Article Records
Google Searches

Learn more about Kristin Kahle-Wrobleski using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Eli Lilly Corporation
Indiana University Indianapolis
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Eli Lilly Corporation
2020
  • Mental Health and Nursing Research Team, Mental Health Promotion Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan. · Department of Health Economics and Outcomes Research, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan, and Yokohama City University, Yokohama, Japan. · Eli Lilly Japan K.K, Kobe, Japan. · Eli Lilly Australia Pty. Limited, West Ryde, Australia. · Eli Lilly and Company, Budapest, Hungary, EU. · Eli Lilly and Company, Indianapolis, IN, USA. · Geriatric Behavioral Neurology Project, New Industry Creation Hatchery Center (NICHe), Tohoku University, Sendai, Japan, Division of Nuclear Medicine, Cyclotron Radioisotope Center (CYRIC), Tohoku University, Sendai, Japan, and The Osaki-Tajiri SKIP Center, Osaki, Japan. · Department of Neurology and Neurobiology of Aging, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan. · Department of Neuropsychiatry, School of Medicine, Keio University, Tokyo, Japan. · ALZCLINIC TOKYO, Tokyo, Japan. · Pubmed 31985460
2018
  • Global Patient Outcomes & Real World Evidence, Eli Lilly Australia, NSW, Australia. · Real World Evidence, Kantar Health, New York, NY, USA. · Global Patient Outcomes and Real World Evidence, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA. · Bio-Medicines, Medical Development Unit, Eli Lilly Japan K.K., Tokyo, Japan. · Health Outcomes, Health Technology Assessment, & Real World Evidence, Medical Development Unit, Eli Lilly Japan K.K., Kobe, Japan, · Pubmed 30038495
  • Global Patient Outcomes & Real World Evidence, Eli Lilly Australia, 112 Wharf Rd, West Ryde, NSW, 2114, Australia. · Health Outcomes Practice, Kantar Health, 11 Madison Ave, Floor 12, New York, NY, 10010, USA. · Global Patient Outcomes & Real World Evidence, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA. · Medical Development Unit, Eli Lilly Japan K.K, 4-15-1, Akasaka, Minato-ku, Tokyo, 107-0052, Japan. · Health Outcomes, Health Technology Assessment, & Real World Evidence, Medical Development Unit, Eli Lilly Japan K.K, 5-1-28, Isogami-dori, chuou-ku, Kobe, 651-0086, Japan. · Pubmed 29898679
  • Eli Lilly and Company Limited, Erl Wood Manor, Sunninghill Road, Windlesham, Surrey, GU20 6PH, UK. · Eli Lilly and Company Limited, Erl Wood Manor, Sunninghill Road, Windlesham, Surrey, GU20 6PH, UK. · Eli Lilly Italia, Sesto Fiorentino, Italy. · Eli Lilly and Company, Indianapolis, IN, USA. · Indiana University School of Medicine, Indianapolis, IN, USA. · Pubmed 29615123
  • Analysis Group, Inc., Boston, MA, USA. · Eli Lilly and Company, Indianapolis, IN, USA. · Pubmed 29154268
2017
  • Kristin Kahle-Wrobleski, PhD, Global Patient Outcomes and Real World Evidence, Eli Lilly and Company, Lilly Corporate Center, Indianapolis IN 46285, USA, Phone: 317-651-9881, Fax: 317-276-5791, Email: · Pubmed 29186278
  • aRICE (The Research Institute for the Care of Older People), Royal United Hospital, Bath, UK. · bEli Lilly Deutschland GmbH, Bad Homburg, Germany. · cEli Lilly and Company, Indianapolis, Indiana, USA. · dEli Lilly Italia S.P.A., Sesto Fiorentino, Italy. · eDepartment of Neurology and Psychiatry, Clinica della Memoria, University of Rome "Sapienza", Rome, Italy. · fGerontopole, Toulouse University Hospital, INSERM 1027, Toulouse, France. · gDivisió d'Avaluació, Catalan Health Service, Barcelona, Spain. · hDepartment of Neurology, Philipps University, Marburg, Germany. · iParc Santari Saint Joan de Déu, CIBERSAM, University of Barcelona, Sant Boi de Llobregat, Barcelona, Spain. · jDivision of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institute, Stockholm, Sweden. · kEli Lilly and Company Limited, Lilly Research Centre, Windlesham, UK. · Pubmed 28611822
  • JEN Associates, Cambridge, Massachusetts. · Eli Lilly and Company, Indianapolis, Indiana. · Pubmed 28329147
  • Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA; Department of Psychiatry, Indiana University School of Medicine, Indianapolis, IN, USA. · Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA. · Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA; Department of Neurology, Indiana University School of Medicine, Indianapolis, IN, USA. · Pubmed 28229126
2016
  • Lilly Research Centre, Eli Lilly and Company Limited, Erl Wood Manor, Sunninghill Road, Windlesham Surrey, GU20 6PH, UK. · Parc Santari Sant Joan de Deu, CIBERSAM, Universitat de Barcelona, Sant Boi de Llobregat, Barcelona, Spain. · Lilly Research Centre, Eli Lilly and Company Limited, Erl Wood Manor, Sunninghill Road, Windlesham Surrey, GU20 6PH, UK. · Eli Lilly and Company, Indianapolis, IN, USA. · Agencia Qualitat I Avaluacio Sanitaries, Barcelona, Spain. · Clinica della Memoria, Department of Neurology and Psychiatry, University of Rome "Sapienza", Rome, Italy. · Department of Neurology, Philipps-University, Marburg, Germany. · RICE (The Research Institute for the Care of Older People), Royal United Hospital, Bath, UK. · Gerontopole, Toulouse University Hospital, INSERM 1027, Toulouse, France. · Division of Neurogeriatrics, Department of Neurobiology, Care Science and Society, Karolinska Institute, Stockholm, Sweden. · Pubmed 27430559
  • Analysis Group, Inc., 111 Huntington Ave, 14th floor, Boston, MA, 02199, USA. · Analysis Group, Inc., 111 Huntington Ave, 14th floor, Boston, MA, 02199, USA. · Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA. · Pubmed 27400711
  • Health Outcomes Practice, Kantar Health, 11 Madison Ave, Floor 12, New York, NY, 10010, USA. · Global Patient Outcomes & Real World Evidence, Eli Lilly Australia, 112 Wharf Rd, West, Ryde, NSW, 2114, Australia. · Global Patient Outcomes & Real World Evidence, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA. · Medical Development Unit, Eli Lilly Japan K.K, 7-1-5, Isogami-dori, chuou-ku, Kobe, 651-0086, Japan. · Health Outcomes, Health Technology Assessment, & Real World Evidence, Medical Development Unit, Eli Lilly Japan K.K, 7-1-5, Isogami-dori, chuou-ku, Kobe, 651-0086, Japan. · Pubmed 27287238
  • Lilly Deutschland GmbH, Bad Homburg, Germany. · Eli Lilly and Company, Indianapolis, IN, USA. · Eli Lilly and Company Limited, Lilly Research Centre, Windlesham, Surrey, UK. · Department of Neurology, Indiana University School of Medicine, Indianapolis, IN, USA. · Eli Lilly and Company, Toronto, Canada. · Eli Lilly and Company, Lilly House, Basingstoke, Hampshire, UK. · Faculty of Science, Liverpool Hope University, Liverpool, UK. · Pubmed 27142529
  • Institute of Psychiatry, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil. · Center for Studies and Research on Aging, Institute Vital Brazil, State University of Rio de Janeiro, Rio de Janeiro, Brazil. · Health Outcomes Practice, Kantar Health, New York, NY, USA. · Lilly Emerging Markets, Eli Lilly de México, Mexico City, Mexico. · Global Patient Outcomes and Real World Evidence, Eli Lilly and Company, Windlesham, Surrey, UK. · Global Patient Outcomes & Real World Evidence, Eli Lilly and Company, Indianapolis, IN, USA. · Pubmed 26011093
2015
  • Eli Lilly and Company, Indianapolis, IN, USA. · Lilly Research Centre, Windlesham, UK. · McGill University, Montreal, Quebec, Canada. · Columbia University, New York, NY, USA. · Harvard Medical School, Boston, MA, USA. · University of California San Diego, San Diego, CA, USA. · Pubmed 28775969
  • Eli Lilly and Company, Indianapolis, Indiana. Electronic address: · Eli Lilly and Company, Indianapolis, Indiana. · Pubmed 25676448
  • Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA. · Alzheimer's Drug Discovery Foundation and Icahn School of Medicine at Mount Sinai, New York, NY, USA. · Optum, Eden Prairie, MN, USA. · Eli Lilly and Company Limited, Windlesham, UK. · Pubmed 25410743
2014
  • Department of Neurology, Rhode Island Hospital & Alpert Medical School of Brown University, Providence, RI, USA. · Eli Lilly & Co, Inc., Indianapolis, IN, USA. · Takeda Development Center Americas, Inc., Deerfield IL, USA. · Bracket, Wayne, PA, USA. · Pfizer, Inc., New York, NY, USA. · Piramal Pharma Inc., Boston, MA, USA. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Lumos Labs, San Francisco, CA, USA. · Global R&D Partners, LLC, San Diego, CA, USA. · Merck & Co., Whitehouse Station, NJ, USA. · Department of Neurology, Mayo Clinic Arizona, Scottsdale, AZ, USA. · European Medicines Agency (EMA), London, UK. · Independent Science Writer, Elverson, PA, USA. · Alzheimer's Association, Chicago, IL, USA. Electronic address: · Pubmed 25458309
2014
  • Kristin Kahle-Wrobleski, Global Health Outcomes, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA, Tel: +1 317 709 6666 Fax: +1 317 433 6590, Email: · Pubmed 25226106
2013
Indiana University Indianapolis
2018
  • Eli Lilly and Company Limited, Erl Wood Manor, Sunninghill Road, Windlesham, Surrey, GU20 6PH, UK. · Eli Lilly and Company Limited, Erl Wood Manor, Sunninghill Road, Windlesham, Surrey, GU20 6PH, UK. · Eli Lilly Italia, Sesto Fiorentino, Italy. · Eli Lilly and Company, Indianapolis, IN, USA. · Indiana University School of Medicine, Indianapolis, IN, USA. · Pubmed 29615123
2017
  • Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA; Department of Psychiatry, Indiana University School of Medicine, Indianapolis, IN, USA. · Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA. · Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA; Department of Neurology, Indiana University School of Medicine, Indianapolis, IN, USA. · Pubmed 28229126
10 Other Locations Show
Yearly article counts 10445341112
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.